Before revision: In 2013, a group of researchers used genome-wide association studies (GWAS) and genome-wide interaction studies (GWIS) to determine the risk of congenital heart defects in patients suffering from Down Syndrome.
After revision: In 2013, a group of researchers used genome-wide association studies (GWAS) and genome-wide interaction studies (GWIS) to determine the risk of congenital heart defects in patients with Down Syndrome.